Evidence map›Paper›PMID 8164679›Full record

ArticleMolecular and cellular biology1994

PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials.

S C Bae, E Ogawa, M Maruyama, H Oka, M Satake, K Shigesada, N A Jenkins, D J Gilbert, N G Copeland, Y Ito

Open access · greenAbstract readComparative Study
In one paragraph

Article in Molecular and cellular biology, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 199 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. RUNX1: A Regulator of NF-kB Signaling in Pulmonary Diseases.Current protein & peptide science · 2018
    Review
  8. Article
  9. Article
  10. Loss of Runx2 in committed osteoblasts impairs postnatal skeletogenesis.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2015
    Article
  11. Article
  12. Article
  13. DNA methylation of RUNX3 in papillary thyroid cancer.The Korean journal of internal medicine · 2012
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

S C BaeDepartment of Viral Oncology, Kyoto University.
E Ogawa
M Maruyama
H Oka
M Satake
K Shigesada
N A Jenkins
D J Gilbert
N G Copeland
Y Ito
Kyoto University · JP

Funding

PROVIDE BASIC CANCER RESEARCHN01CO074101 · CO · ADVANCED BIOSCIENCE LABORATORIES, INC. · PI VANDE WOUDE, GEORGE F · 1987 to 1994
–
NCI NIH HHS N01-CO-74101
6 · The paper itself

Abstract

A murine transcription factor, PEBP2, is composed of two subunits, alpha and beta. There are two genes in the mouse genome, PEBP2 alpha A and PEBP2 alpha B, which encode the alpha subunit. Two types of the alpha B cDNA clones, alpha B1 and alpha B2, were isolated from mouse fibroblasts and characterized. They were found to represent 3.8- and 7.9-kb transcripts, respectively. The 3.8-kb RNA encodes the previously described alpha B protein referred to as alpha B1, while the 7.9-kb RNA encodes a 387-amino-acid protein, termed alpha B2, which is identical to alpha B1 except that it has an internal deletion of 64 amino acid residues. Both alpha B1 and alpha B2 associate with PEBP2 beta and form a heterodimer. The alpha B2/beta complex binds to the PEBP2 binding site two- to threefold more strongly than the alpha B1/beta complex does. alpha B1 stimulates transcription through the PEBP2 site about 40-fold, while alpha B2 is only about 25 to 45% as active as alpha B1. Transactivation domain is located downstream of the 128-amino-acid runt homology region, referred to as the Runt domain. Mouse chromosome mapping studies revealed that alpha A, alpha B, and beta genes are mapped to chromosomes 17, 16, and 8, respectively. The last two genes are syntenic with the human AML1 on chromosome 21q22 and PEBP2 beta/CBF beta on 16q22 detected at the breakpoints of characteristic chromosome translocations of the two different subtypes of acute myeloid leukemia. These results suggest that previously described chimeric gene products, AML1/MTG8(ETO) and AML1-EAP generated by t(8;21) and t(3;21), respectively, lack the transactivation domain of AML1.

Indexed as

Chromosome MappingProto-Oncogene ProteinsAmino Acid SequenceAnimalsBase SequenceChloramphenicol O-AcetyltransferaseChromosomes, Human, Pair 16Chromosomes, Human, Pair 21Cloning, MolecularCore Binding Factor Alpha 2 SubunitCore Binding Factor alpha SubunitsCore Binding Factor beta SubunitCrosses, GeneticDNA-Binding ProteinsDNA PrimersFemaleChloramphenicol O-AcetyltransferaseCore Binding Factor Alpha 2 SubunitCore Binding Factor alpha SubunitsCore Binding Factor beta SubunitDNA-Binding ProteinsDNA PrimersMacromolecular SubstancesNeoplasm ProteinsProto-Oncogene ProteinsRUNX1 protein, humanRunx1 protein, mouseTranscription Factor AP-2Transcription Factors

Identifiers

PMID8164679
PMCPMC358691
OpenAlexW2141947090

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.